September 2019 Briefing – Psychiatry
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for September 2019. This roundup includes the latest...
Some Nutritional Supplements May Aid Mental Health Conditions
Nutrient supplements had good safety profiles, no known contraindications with psychiatric medications
USPSTF Finds Evidence Lacking to Prevent Illicit Drug Use in Youth
Evidence insufficient to recommend primary care interventions to prevent, cut drug use in youth
Most Severe Forms of Mental Illness Lead to Highest CVD Risk
Findings seen in both male and female veterans with psychotic disorders such as schizophrenia
Recommendations Updated for Management of Pediatric ADHD
Recommendations include screening for comorbid conditions, understanding ADHD is chronic condition
ASCO: More Than One in Five Millennials Use E-Cigarettes
Most adults agree e-cigarettes cause cancer while more Millennials, Gen Z believe them to be harmless
Mental Health Service Use Up After Bariatric Surgery
Deliberate self-harm presentations to an ED increased fivefold after bariatric surgery
Eight Touchpoints May Predict Opioid Overdoses
These factors identify more than half of opioid overdose decedents and may represent prevention opportunities
2009 to 2017 Saw Pediatric Developmental Disability Increase
Significant increases in prevalence of any developmental disability and in ADHD, ASD, intellectual disability
Primary Care Use Aids Patients With Diabetes and Coexisting Psych Disorders
More primary care for patients with mental health, substance use disorders may affect diabetes severity
